Consequently, it can also be inferred that PSPW may curb gluconeogenesis and enhance glycogen synthesis by activating the insulin-mediated PI3K-AKT-FoxO1/GSK3 signaling pathway, thereby ameliorating insulin resistance and hyperglycemia. The gene discussed is INS; the disease is Insulin resistance.